Reassessment of the cefaclor breakpoint for Streptococcus pneumoniae

International Journal of Antimicrobial Agents

Volumn 23, Issue 4, 2004, Pages 337-342

  MacKenzie, Fiona M ^a   Milne, Kathleen E ^a   Gould, Ian M ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cefaclor; MICs; S. pneumoniae

Indexed keywords

CEFACLOR; CEFUROXIME;

ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIOSTASIS; BACTERIUM ISOLATE; BIOASSAY; DRUG HALF LIFE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CEFACLOR; CEFUROXIME; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE;

EID: 1842789607     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.09.019     Document Type: Article

References (12)

1. Craig W.A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26:1998;1-10.
2. Craig W.A., Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Paed. Infect. Dis. J. 15:1996;255-259.
3. Brumfitt W., Hamilton-Miller J.M.T. Cefaclor into the millennium. J. Chemom. 11:1999;163-178.
4. Dagan R., Abramson O., Leibovitz E.et al. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J. Infect. Dis. 176:1997;1253-1259.
5. Wilson R. Cefaclor. Int. J. Antimicrob. Agents. 2:1993;185-198.
6. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 5th ed. NCCLS document M7-A5. Supplemental Tables M100-S10 (M7). Wayne, PA: NCCLS; 2000.
7. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 5th ed. NCCLS document M7-A5. Wayne, PA: NCCLS; 2000.
8. Preston D.A., Turik M. Cefaclor: a contemporary look at susceptibility of key pathogens from around the globe. J. Chemom. 10:1998;195-202.
9. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Approved Standard M7-A4. Wayne, PA: NCCLS; 1997.
10. O'Callaghan CH, Kirby SM. Methods of antibiotic assay - cephalosporins. In: Laboratory methods in antimicrobial chemotherapy. New York: Churchill Livingstone; 1978.
11. Gould I.M., Wilson D., Milne K., Paterson A., Golder D., Russell D. Interaction of imipenem with erythromycin and tetracycline assessed by microdilution checkerboard techniques. Antimicrob. Agents Chemother. 35:1991;2407-2409.
12. Pichichero M.E. Recurrent and persistent otitis media. Paed. Infect. Dis. J. 19:2000;911-916.